CJC-1295
IPAMORELIN
CJC-1295 and Ipamorelin are synthetic peptides frequently studied together in laboratory research settings for their potential effects on growth hormone secretion, metabolic function, and body composition. Both peptides are strictly for research purposes and not approved or intended for human use or therapeutic applications.
​
Overview of CJC-1295 | Ipamorelin Research
Composition and Origin
-
Synthetic Peptides:
-
CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH), modified for extended half-life (Teichman et al., 2006).
-
Ipamorelin is a selective growth hormone secretagogue designed to mimic ghrelin and stimulate growth hormone release (Raun et al., 1998).
-
-
Research-Oriented Use: Both peptides are designated solely for laboratory research to examine endocrine, metabolic, and body composition-related mechanisms.
Key Areas of Animal Research
-
Growth Hormone Secretion: Animal studies have investigated how these peptides may enhance natural growth hormone release, potentially influencing various physiological functions (Teichman et al., 2006; Raun et al., 1998).
-
Metabolic and Body Composition Effects: Research has explored their possible roles in metabolic regulation, fat metabolism, and muscle composition in preclinical animal models (Raun et al., 1998).
-
​
Important Reminders for Research Use
-
Sterile Handling: Maintain sterile conditions when handling peptides to prevent contamination.
-
Proper Storage: Store peptides under refrigeration according to provided guidelines.
-
Acknowledgment of Use: By purchasing CJC-1295 and Ipamorelin, you explicitly acknowledge these peptides are strictly for laboratory research purposes and are not intended for human consumption or therapeutic use.
References:
-
Teichman, S. L., Neale, A., Lawrence, B., Gagnon, C., Castaigne, J.P., & Frohman, L. A. (2006). Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. Journal of Clinical Endocrinology & Metabolism, 91(3), 799-805.
-
Raun, K., Hansen, B. S., Johansen, N. L., Thøgersen, H., Madsen, K., & Knudsen, L. B. (1998). Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology, 139(5), 552-561.
Disclaimer:
CJC-1295 and Ipamorelin are strictly intended for research purposes only and have not been evaluated by the FDA. These peptides are not approved for human use or therapeutic applications. No claims are made regarding their effectiveness in diagnosing, treating, curing, or preventing any disease, condition, or illness. All referenced research pertains exclusively to preclinical animal studies or controlled laboratory settings.
INGREDIENTS
CJC-1295 IPAMORELIN 5mg / 3ml
​​​​
199 per vial
​
Buy 2 Get 1 Free 398
![PEPTIDE VIALS] (7).png](https://static.wixstatic.com/media/0d6197_1433210c6cda4280bd567ada84b96b87~mv2.png/v1/fill/w_280,h_209,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/PEPTIDE%20VIALS%5D%20(7).png)
![PEPTIDE VIALS] (8).png](https://static.wixstatic.com/media/0d6197_248f0aa5114e40e996bea7bac6a3da0c~mv2.png/v1/fill/w_252,h_209,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/PEPTIDE%20VIALS%5D%20(8).png)
CJC-1295 |IPAMORELIN
RESEARCH PEPTIDE
.png)
Mobile NAD+ IV Now available
Experience the convenience of IV therapy in the comfort of your own home. Our professional team brings personalized hydration and wellness treatments directly to you, ensuring expert care without the need to travel.
Why Choose At Home IV Therapy?
-
Convenience: Receive treatment without leaving home.
​
-
Time-Saving: Skip the clinic and save time.
​
-
Privacy: Discreet care in your personal space.
​
-
Comfort: Relax in familiar surroundings.
​
-
Flexibility: Perfect for when you can’t travel.
​
-
Custom Care: Personalized treatments delivered to you.